Frontlight ResearchEarly access
Trial site
Care Access - Fayetteville
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Obesity5 trials
- Type 2 diabetes5 trials
- Chronic kidney disease2 trials
- Alzheimer disease1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 36 trials
- Status
- Active, not recruiting5 trials
- Completed1 trial
- Lead sponsor
- Eli Lilly and Company6 trials
Running trials
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026